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Abstract
Background: Cholix toxin is an ADP-ribosyltransferase found in non-O1/non-O139 strains of Vibrio cholera.T h e
catalytic fragment of cholix toxin was characterized as a diphthamide dependent ADP-ribosyltransferase.
Results: Our studies on the enzymatic activity of cholix toxin catalytic fragment show that the transfer of ADP-ribose to
toxin takes place by a predominantly intramolecular mechanism and results in the preferential alkylation of arginine residues
proximal to the NAD
+ binding pocket. Multiple arginine residues, located near the catalytic site and at distal sites, can be
the ADP-ribose acceptor in the auto-reaction. Kinetic studies of a model enzyme, M8, showed that a diffusible intermediate
preferentially reacted with arginine residues in proximity to the NAD
+ binding pocket. ADP-ribosylarginine activity of cholix
toxin catalytic fragment could also modify exogenous substrates. Auto-ADP-ribosylation of cholix toxin appears to have
negatively regulatory effect on ADP-ribosylation of exogenous substrate. However, at the presence of both endogenous
and exogenous substrates, ADP-ribosylation of exogenous substrates occurred more efficiently than that of endogenous
substrates.
Conclusions: We discovered an ADP-ribosylargininyl activity of cholix toxin catalytic fragment from our studies in
auto-ADP-ribosylation, which is mediated through diffusible intermediates. The lifetime of the hypothetical intermediate
exceeds recorded and predicted lifetimes for the cognate oxocarbenium ion. Therefore, a diffusible strained
form of NAD
+ intermediate was proposed to react with arginine residues in a proximity dependent manner.
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Background
ADP-ribosyltransferases (ADPRTs) constitute a broadly
distributed family of prokaryotic and eukaryotic enzymes
that catalyze the transfer of an ADP-ribose moiety from
NAD
+ to one or more substrates. The protein substrates
of ADPRTs are heterogeneous and include eukaryotic
elongation factor 2 (eEF2) [1,2], actin [3], vimentin [4],
ezrin/radixin/moesin proteins [5], various heterotrimeric
and small monomeric GTPases [6,7], the adapter proteins
CRK-I and CRK-II [8], human α-defensin (HNP-1) and
human β-defensin-1 (HBD1) [9,10], and cell surface mole-
cules [11,12]. A family of ADPRTs ADP-ribosylate eEF2
on a post-translationally modified histidine residue called
diphthamide [13]. Other ADPRTs transfer ADP-ribose
to arginine, cysteine, glutamate, or asparagine residues
[14,15]. Many ADPRTs also possess NAD
+ glycohydro-
lase activity attributed to the attack by hydroxyl ion on
the activated NAD
+ transition state [16]. A number of
ADPRTs exhibit auto-ADP-ribosylation activity, including
diphtheria toxin [17,18], cholera toxin [19], Clostridium
limosum C3 exoenzyme [20], Pseudomonas aeruginosa
exoenzyme S [21], Escherichia coli heat-labile entero-
toxin [22], Neisseria meningitidis ADP-ribosylargininyl
transferase, NarE [23], and several mammalian ADPRTs
[24-26]. Auto-ADP-ribosylation of APDRTs has been
shown to have functional consequences for the en-
zyme. For example, the auto-reaction of poly-ADP-
ribose polymerase (PARP) has been reported to reduce
its DNA-binding affinity, which in turn plays an important
role in regulating the PARP response to DNA damage
stimuli [27]. Similarly, auto-ADP-ribosylation of mamma-
lian ADP-ribosyltransferase 5 (ART5) redirects the enzyme
catalytic focus from NAD
+ glycohydrolase activity to ADP-
ribosyltransferase activity [28]. Auto-ADP-ribosylation has
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C3 exoenzyme, P. aeruginosa exoenzyme S, and Neisseria
meningitides ADP-ribosylargininyl transferase, NarE [20,21,23].
Cholix toxin (ChxA) [15,29] and recently identified cho-
lix toxin variants [30] were identified by genomic se-
quencing and homology comparisons in Vibrio cholera
non-O1/non-O139 strains. Features of the primary se-
quences that were considered relevant to a phylogenet-
ically conserved structural core supporting enzymatic
function included an YXHG and an YXnY motif and a
low but significant degree of homology to P. aeruginosa
exotoxin A [15]. Many of the enzymatic attributes of cho-
lix toxin have been established by the expression, catalytic
characterization and determination at high resolution of a
three dimensional crystal structure of the toxin and its
catalytic subunit [2]. The results suggest that cholix toxin
is a diphthamide-specific ADP-ribosyltransferase with a
general domain organization and topology similar to that
of exotoxin A. Members of the eEF2-specific ADPRTclass
are both phylogenetically and enzymatically distinct from
other ADPRTs, and their common unique substrate,
diphthamide, has been suggested to directly participate
in the catalysis [31]. This class of ADPRTs has an elon-
gated loop structure that is predicted or confirmed to
significantly rearrange upon contact with eEF2 and
that likely mediates the majority of interactions between
enzyme and substrate [2,31,32]. Data from crystallo-
graphic and kinetic studies suggest the ADP-ribosylation
of eEF2 is mediated through a random third order SN1r e -
action, though the ribosyl-diphthamide bond adopts the α
conformation consistent with the stereo inversion ex-
pected of an SN2 mechanism [33]. Here we characterized
the process of the auto-ADP-ribosylation reaction of cho-
lix toxin and evidenced that a metastable diffusible inter-
mediate was generated upon the enzyme activation then
diffused to react with arginine residues of the enzyme
in a proximity dependent manner. We also showed
that wild type cholix toxin catalytic fragment (abbr. as
CTc) could ADP-ribosylate oligo argininyl peptides and
eEF2 (H715R) mutant in which the post-translationally
modified diphthamide at His715 was replaced by arginine.
We propose that this mechanism can be used to engineer
ADP-ribosyltransferases with alternative substrate specifi-
city as long as there is an arginine residue or other ADP-
ribose acceptors close to the catalytic site of the enzyme.
Results and discussion
An enzymatic pathway is involved in auto-ADP-ribosylation
To characterize the enzymatic activity of cholix toxin we
expressed the catalytic fragment under the control of the
araBAD promoter as a translational fusion to a secB
pathway-dependent signal peptide and assessed the ability
of the periplasmic fraction to carry out ADP-ribosylation
using biotinyl-NAD
+ as a biotinyl-ADP-ribose donor. Initial
experiments revealed the presence of an arabinose-inducible
biotin-labeled band corresponding to the molecular weight
of the catalytic fragment. Mutants Y493A, E581Q, and
Y493A/E581Q (abbr. as YEDQ in the following) exhibited
reduced biotinylation intensity compared to wild type and
mutant E579Q, suggesting the catalytic fragment was cap-
able of utilizing itself as a substrate (Figure 1A). The biotin
labeled or
32P-labeled purified enzymes were also ob-
served (Figure 1B and C), suggesting that host factors are
not required. The possibility that the mutant forms had
undergone structural changes resulting in a loss of sub-
strate potential was minimized by the finding that the cir-
cular dichroism spectra of wild type and mutant proteins
were substantially identical (Figure 1D). The auto-ADP-
ribosylation and NAD
+ glycohydrolase activities of the
purified enzymes were also assessed under comparable
conditions by a fluorescence-based assay (Figure 1E). The
results indicate that the auto-ADP-ribosylation and NAD
+
glycohydrolase activities of CTc are highly concordant.
Mutations on any one of the conserved residues involved
in catalysis resulted in loss of the auto-ADP-ribosylation
activity (Figure 1A-C; Additional file 1A). These residues
include E581, the catalytic residue; Y493 and Y504, two
tyrosine residues binding to the aromatic group of NAD
+;
H460, providing the structural integrity of the catalytic
site [15].
Excess free ADP-ribose (up to 125-fold above assay con-
centration for
32P-NAD
+ or 636-fold for biotinyl-NAD
+)
did not significantly inhibit either
32P- or biotinyl-ADP-
ribosylation signals in the auto-reaction of CTc, suggesting
that a non-enzymatic pathway resulting from the initial
generation of ADP-ribose by NAD
+ glycohydrolase activity,
followed by non-enzymatic addition, does not play a major
role in contributing to the observed auto-ADP-ribosylation
reaction (Figure 1F and G). However, we also observed in-
creased biotin substitution of the inactive mutant CTc
(YEDQ) that had been incubated with increasing amounts
of biotinyl-NAD
+, which may be contaminated with some
reactive NAD
+ intermediates or ADP-ribose from the
synthesis of biotinyl-NAD
+ to cause the increased back-
ground biotin signals without catalytic activity (Figure 2A).
Biotinyl-NAD
+ bears the biotin substitution on the ad-





14C labeling on the nicotinamide moiety. When
biotinyl-NAD
+ was substituted by [carbonyl-
14C]-NAD
+,
there was no significant difference in
14Ci n c o r p o r a t i o n
between active and inactive enzymes even when as high as
100 to 200 μM of [carbonyl-
14C]-NAD
+ was used in the
auto-reactions (Figure 2B). In contrast, active enzyme CTc
showed ~4-fold higher biotin substitution than inactive
mutant CTc(YEDQ) when 100 μMb i o t i n y l - N A D
+ was
used. Overall, these data suggest that the increase in biotin
substitution caused by the enzymatic activity of CTc is an
ADP-ribosylation reaction.
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To understand if auto-ADP-ribosylation of cholix toxin
involves intra- or inter-molecular modification, a catalyt-
ically active higher molecular weight form of CTc was
prepared by fusion of the catalytic fragment to an im-
munoglobulin constant domain (abbr. as Ig-CTc), yield-
ing an active enzyme with a molecular weight of 70 kDa.
The resulting protein was mixed with mutant catalytic
fragment in 1:5 molar ratio. The catalytically active form
of the enzyme, Ig-CTc, was found to be preferentially
substituted with biotinyl-ADP-ribose (Figure 3A). A re-
duced level of substitution with biotinyl-ADP-ribose was
found for Y493A mutant protein that had been incu-
bated at high concentration with Ig-CTc, which could be
due to residual activity of the mutant enzyme or could
reflect the occurrence of trans-ADP-ribosylation at high
substrate concentration. Similarly, when purified recom-
binant full-length wild type cholix toxin (abbr. as CXT)
was mixed with the catalytically inactive mutant, Y493A,
or the catalytically inactive full-length cholix toxin E581A
mutant was mixed with the wild type CTc, the auto-ADP-
ribosylation of cholix toxin preferentially took place on the
catalytically active form (Figure 3A). Together, these data
support the view that auto-ADP-ribosylation of cholix toxin
favors intramolecular transfer of the ADP-ribose moiety.
Multiple arginines are the target residues
ADP-ribosyl adducts have different stabilities to neutral
hydroxylamine: under conditions for which the half life
of ADP-ribosylated glutamate is about 3–10 minutes,
the half life of ADP-ribosylated arginine is about 120 mi-
nutes and the half lives of ADP-ribosylated cysteine and
asparagine are immeasurably large [34]. As shown in the
Figure 3B, the biotin substitution of the wild type and
two active mutants, E579Q and E579R, showed no re-
duction following exposure to 0.5 M NaCl but fell by
half after two hours of 0.5 M neutral hydroxylamine
treatment at 37°C. Under these conditions there were lit-
tle or no changes in the quantity or mobility of proteins
as a result of either exposure. These data are consistent
with the view that a significant fraction of biotinyl-ADP-
ribose substitutions are the result of modification of ar-
ginine residues.
Since the ADP-ribosyl-glutamate linkage is labile in
the neutral hydroxylamine treatment, we substituted two
glutamate residues near the NAD
+ binding pocket with
lysine residues to create mutants E484K and/or E486K.
None of these substitution mutations reduced the biotin
signals on the auto-ADP-ribosylated enzymes (Additional
file 1B). We therefore focus our study on the modification
of arginine target residues.
To identify candidate residues for the auto-ADP-
ribosylation, 14 arginine residues in the catalytic frag-
ment were mutated to alanine residues. The extent of
auto-ADP-ribosylation was significantly reduced after
incubation of the R506A, R519A, R525A, R530A, R535A,
R540A, or R543A mutant proteins with biotinyl-NAD
+
substrate (Figure 3C and D), indicating these arginine resi-
dues may be the targets of auto-ADP-ribosylation. How-
ever, some mutant proteins also exhibited lower levels of
NAD
+ glycohydrolase activity than wild type catalytic frag-
ment (Figure 3E) especially in the case of the R506A,
R525A and R530A mutant proteins. Therefore, we re-
placed Arg506, Arg525, and Arg530 with glutamine or
lysine, which has greater steric bulk than alanine (Figure 3C).
The NAD
+ glycohydrolase activity of R506Q, R506K,
R525Q, or R525K was detectable at a level similar to
that of other mutants and auto-ADP-ribosylation was
also detected, suggesting other arginine residues than
these can be ADP-ribosylated. All the attempts to re-
place Arg530 resulted in unstable enzymes with very
poor activity and a low level of protein expression, in-
dicating the enzyme is structurally sensitive to Arg530
modification. With the exception of Arg530 mutants,
none of which were active, none of the single amino acid
substitutions completely abolished auto-ADP-ribosylation,
leads to the hypothesis that multiple arginine residues
could serve as ADP-ribose acceptors.
(See figure on previous page.)
Figure 1 An enzymatic pathway is involved in auto-ADP-ribosylation of CTc. (A) Biotin signals are detected in the periplasmic fractions
of E.coli lysate expressing wild type and mutant cholix toxin catalytic fragments (SA). The same blot was re-blotted with rabbit anti-CTc antibody




+ (C). The blots shown are representative of multiple independent experiments. (D) The structures of these mutants were analyzed
by circular dichroism (CD) spectrometry. (E) NAD
+ glycohydrolase activity (left panel) and auto-ADP-ribosylation activity (right panel) were quantified
by 96-well plate based assays. Data are summarized from three independent experiments. Error bars show the standard deviation of the composite
data. Asterisks indicate significant reduction of enzyme activity as compared to the wild type CTc with *, p-value<0.004; **, p-value<0.0001.
(F) Various concentrations of free ADP-ribose were added to the auto-ADP-ribosylation reaction. As a control, the
32P-ADP-ribosylation signals on
CTc were removed by phosphodiesterase I treatment. Asterisk indicates significant reduction of
32P-auto-ADP-ribosylation signal of the treated over
the untreated samples with p-value<0.01. Data shown is representative of three independent experiments. Error-bars show the standard error of
mean (SEM). Statistic analysis was done by student t-test. (G) Excess amount of free ADP-ribose was added to the ADP-ribosylation buffer containing
3 μM purified wild type CTc and 50 μM biotinyl-NAD
+ at 37°C for 1 hour. The biotinyl-ADP-ribosylation signal was detected by IRDye800CW-SA. In all
panels, arrowheads indicate the auto-ADP-ribosylated CTc and arrows indicate the detection of CTc by anti-CTc antibody.
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electrophoresis and MS/MS analysis
To support this hypothesis, we analyzed the auto-ADP-
ribosylation of CTc using NAD
+ as ADP-ribose donor
by two-dimensional (2-D) electrophoresis. CTc has an
isoelectric point (pI) of 5.5. One ADP-ribose addition to
this fragment shifts its pI ~0.2 pH units. Following auto-
reaction of the catalytic fragment, multiple spots shifted
toward the acidic pH from the spot of CTc were de-
tected by 2-D electrophoresis compared to the sample
without incubation with NAD
+ (Figure 4B, circled), in-
dicating multiple residues being modified in the same
protein. An additional spot found in the sample prior
to incubation with NAD
+ may result from auto-ADP-
ribosylation in vivo, or from other post-translational
modifications that occurred in the E.coli strain from
which CTc was expressed. To map the location of the
ADP-ribosylated arginines, the auto-ADP-ribosylated
CTc was digested with LysC, predicted to cleave the
CTc into three major peptides: peptide 423–488 (the-
oretical pI/MW: 5.85/7.4 kDa), peptide 489–508 (the-
oretical pI/MW: 8.51/2.2 kDa) and peptide 509–616
(theoretical pI/MW: 4.61/11.8 kDa). The LysC digested
auto-ADP-ribosylated CTc was resolved in pH 3–10
Figure 2 Biotin signals on the self-modified wild type CTc is an ADP-ribosylation reaction. (A) Purified wild type CTc or inactive mutant
CTc(YEDQ), was incubated with various concentrations of biotinyl-NAD
+. The folds of fluorescence intensity increase between CTc and CTc(YEDQ)
were shown on the top of each pair of bar graph. (B) Purified CTc or CTc(YEDQ) was incubated with various concentrations of [carbonyl-
14C]-
NAD
+ at 37°C for 1 hour. Asterisk indicates the control group in which 293 cell lysate was added to CTc or CTc(YEDQ) to measure
14C incorporation into the
TCA precipitants. Data were summarized from two separated experiments.
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Figure 3 Intramolecular transfer of ADP-ribose to multiple arginines in the auto-reaction. (A) Mixing marked enzymes experiments. Active
Ig-CTc was mixed with inactive mutant Y493A (top panel); active full-length cholix toxin, CXT (WT), was mixed with mutant Y493A (middle panel);
inactive mutant CXT(E581A) was mixed with active CTc (bottom panel) in auto-ADP-ribosylation assays. Molar concentrations shown on the top
of each blot are the concentrations of active enzyme. The left blots (SA) were detected by IRDye800CW-SA; the same blots were re-probed with
polyclonal rabbit anti-CTc antibody shown on right (IB). (B) Neutral hydroxylamine assays. Auto-ADP-ribosylation reaction was carried out with
periplasmic fractions of E. coli lysate expressing wild type or mutant CTc. The products were subjected to 0.5 M NH2OH (pH7.5) or 0.5 M NaCl
treatment at 37°C for 2 hours. The blot shown is representative of multiple experiments. (C-E) Single amino acid substitution mutation
studies. A set of representative data from the detection of biotin signals on wild type or different mutants was shown in (C). The fluorescence intensity
of SA (IRDy-SA) was normalized with the Coomassie Blue intensity (CB) to obtain the IRDy-SA/CB ratio as a semi-quantitative auto-ADP-ribosylation
measurement of each enzyme. Data were summarized from four sets of experiments (D). Asterisk indicates significant reduction of auto-ADP-ribosylation
activity. NAD
+ glycohydrolase activities of wild type and mutant enzymes are shown in (E).
Figure 4 Detection of multiple ADP-ribosylarginines by two-dimensional (2-D) electrophoresis. The amino acids sequences of CTc fused
with outer membrane signal peptide was shown in (A). CTc was incubated with or without 250 μM NAD
+ (B). CTc incubated with or without
NAD
+ was further digested with LysC prior to peptide 2-D electrophoresis (D). Amino acid sequences of three major predicted proteolytic
products are shown in (C). Circle I indicates the partially digested peptide 489–616. Circle II indicates spots shifted from the auto-ADP-ribosylated
peptide 509–616. Spots A and B are peptides 509–616 and 423–488, respectively.
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lysis to separate the fragments. Two fragments (peptide
423–488 and peptide 509–616) were detected in gel spots
B and A, respectively. Peptide 489–508 was too small to
be observed in the peptide gel. However, a partial digest
product spanning residues 489–616 was detected from
which multiple shifted spots were detected (Figure 4D, cir-
cle I). At least three modified spots arising from the un-
modified peptide 509–616 were detected in Coomassie
Blue stained 2-D peptide gels (Figure 4D, circle II).
These spots were missing from gels prepared from the
CTc which was not incubated with NAD
+.P e p t i d e
509–616 contains several arginine residues (Arg525,
Arg530, Arg540, Arg543 or Arg566) identified by re-
verse mutagenesis studies to be the targets for auto-
ADP-ribosylation of CTc.
We also confirmed the ADP-ribosylarginine modifica-
tions by MS/MS analysis. The ADP-ribose moiety of
ADP-ribosylated peptide is labile to the MS or MS/MS
detection process. A two-step collision method was
performed to remove the modification group (i.e., the
ADP-R-carbodiimide moiety) with an in-source decay
done in the tandem mass spectrometer [35]. The prod-
uct from the first collision was then subject to the sec-
ond collision to fragmentize the peptide chain with the
small marker moiety to locate and determine the amino
acid sequences. The combination of selection candidate
peptides by the precursor ion scanning with ADP-R-
carbodiimide as the marker ion and further fragmenta-
tion of the ion of the ADP-R-carbodiimide-derived
peptides provided highly specific and reliable data applic-
able for MS/MS database searching for de novo peptide
sequences. The ADP-ribosylargininyl peptide yields a
product peptide in which arginine is replaced with or-
nithine (called Orn peptide) after first collision. From
spot A (Figure 4D), we sequenced two Orn peptides,
YGLPT/Orn/AERD and ARGVML/Orn/VYIPRASLE, in-
dicating that the corresponding arginine positions Arg519
and Arg530 were ADP-ribosylated (Additional file 2). From
the circled spots of Figure 4B and circles I and II of
Figure 4D, four Orn peptide signals were detected to
be Orn/FY/Orn/TNTPLE (for ADP-ribosylated Arg540
and Arg543), RFY/Orn/TNTPLE (for ADP-ribosylated
Arg543), Orn/FYRTNTPLE (for ADP-ribosylated Arg540),
and HITQVIGHSLPL/Orn/NEAFTGPE (for ADP-ribosylated
Arg566). The Orn peptide containing Arg530 was un-
expectedly detected in this study. The Arg530 position
is sensitive to modification and the buried side-chain
of Arg530 makes it unlikely to be ADP-ribosylated in
its native conformation. We therefore reason the modifi-
cation of Arg530 occurred artificially during the overnight
iso-electrofocusing step when the enzyme was exposed to
the 2-D sample buffer. The urea and detergent in the sam-
ple buffer could expose the side chain of Arg530 from its
native position to react with the diffusible intermediate.
Although we removed free NAD
+ from the sample by
gel filtration chromatography at the end of auto-ADP-
ribosylation reaction prior to 2-D analysis, we may not
have completely removed the enzyme bound fractions
of NAD
+. Arg530 is located close to the NAD
+ binding
pocket geometrically in the native 3-D structure of CTc.
Identification of arginine target residues by direct and
reverse mutagenesis
In our efforts to identify the auto-ADP-ribosylation tar-
get residues, a series of composite lysine to arginine re-
placement mutants were created as shown in Table 1, in
which each successive mutant contained all the modifi-
cations of its parental template. Mutant M1 was con-
structed by introducing the R506K and R566K mutations
into wild type catalytic fragment. M1 was used as a tem-
plate to make mutant M2, which has additional R426K,
R473K and R629K mutations. Arg530 was retained in all
mutants because the protein integrity and catalytic activity
are sensitive to its replacement. The mutants were puri-
fied and analyzed for their auto-ADP-ribosylation and
NAD
+ glycohydrolase activities (Table 1). Mutant M1 ex-
hibited a reduction of biotin signal compared to wild type
enzyme, implicating Arg506 and/or Arg566 as potential
targets. Similarly, the degree of biotin substitution was de-
creased in M5-2, M4392, and M4421 compared to the
parental M4 template, implicating Arg540 and Arg543 as
potential targets. The reduction of biotinylation from M5-
4 to M6 could be attributed to the R535K mutation and
the reduction from M6 to M7 could be attributed to the
R525K mutation. Introduction of R479K into the M7 tem-
plate to make mutant M8 resulted in apparent abolition of
biotinylation, suggesting Arg479 is an important target.
However, when the R479K mutation was introduced into
the context of mutant M4 to form M4781 mutant, signifi-
cant biotinylation was detected, indicating Arg479 is not
the sole ADP-ribose acceptor. The loss of substrate activ-
ity by mutant M8 coincided with a restoration of NAD
+
glycohydrolase activity, suggesting the principal explan-
ation for the diminished degree of biotinylation seen in
this mutant is not extinction of catalytic activity (Table 1).
Based on these data, Arg479, Arg506, Arg525, Arg535,
Arg540, Arg543, Arg566 are potential target residues for
auto-ADP-ribosylation.
Mutant M8 exhibited nearly undetectable auto-ADP-
ribosylation and the background biotinyl signals of M8
were similar to those of the inactive mutant, M8(YEDQ)
(Figure 5A). M8 mutant contains 13 arginines to lysines
replacement mutations except Arg530. Arg530 has a bur-
ied (solvent non-exposed) side chain, which makes it less
likely to be the target of auto-ADP-ribosylation in its na-
tive conformation. We therefore chose M8 as template
to generate lysine (K) to arginine (R) reverse mutants.
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(K506R), M8(K525R), M8(K540R), M8(K543R) and M8
(K566R) were all found to regain biotinylation signal in-
tensity (Figure 5B), indicating multiple arginines can serve
as ADP-ribose acceptors in the auto-ADP-ribosylation of
M8 derived mutants. Together, we identified Arg506,
Arg519, Arg525, Arg535, Arg540, Arg543 and Arg566
to be the target residues for auto-ADP-ribosylation.
Diffusible intermediates
The locations of these arginine target residues are not
restricted near the NAD
+ binding pocket but also found
at distal sites of the enzyme (PBD entry 2Q6M; [2]). In
conjunction with the finding of intramolecular transfer
of ADP-ribose to the active enzyme itself, we propose a
mechanism by which a diffusible intermediate is created
upon enzymatic activation and diffuses to react with ar-
ginine residues.
To further support this mechanism, we determined
the auto-ADP-ribosylation rate of individual arginine
residues using M8 K to R reverse mutants. Each M8 K
to R reverse mutant contains Arg530 and one additional
arginine residue. Using the method described in Kinetic
Experiments, we compared the auto-ADP-ribosylation
rates of six selected arginine target residues located at
the proximal and distal sites of the NAD
+ binding pocket
(Table 2). M8(K506R) containing Arg506 target residue
located at the end of the NAD
+ binding loop had the high-
est auto-ADP-ribosylation rate, ~16-20-fold faster than
the auto-ADP-ribosylation rates of M8(K519R) and M8
(K525R). Under the assumption that these enzymes
should have similar Km,biotin-NAD+ to make the correlation
of the reaction rates with the distances of the acceptor res-
idues in a simplified diffusion model, we normalized the
Vmax of M6(K506R), M8(K519R), and M8(K525R) with
their corresponding Km,b i o t i n - N A D + , then the normalized
auto-ADP-ribosylation rate of Arg506 is approximately
4 ~ 5-fold faster than those of Arg519 and Arg525, which
are located on the substrate recognition loop near the
NAD
+ binding pocket. The auto-ADP-ribosylation rates
of Arg540, Arg543 and Arg566, located at the distal or the
opposite face of the NAD
+ binding pocket, were low and
highly variable among the inter- and intra-experimental
repeats. Although the Km,biotin-NAD+ of M8(K543R) is
2-fold less than M8(K506R), the normalized auto-ADP-
ribosylation rate (Vmax) of M8(K543R) is ~200-fold lower
than that of M8(K506R), suggesting the electronic envir-
onment in the solution and the stability of the diffusible
intermediate may affect the measured modification rates
more pronouncedly in the auto-ADP-ribosylation of the
three distal arginines. These data support that the auto-
ADP-ribosylation is mediated through a diffusible inter-
mediate that reacts with its target residues in a primarily
proximity-controlled mechanism.
To test what other amino acids the diffusible inter-
mediate would react with, the Lys479 or Lys525 in M8
mutants were substituted with other potential ADP-
ribose acceptors including cysteine, asparagine and glu-
tamine. Most of these substitutions yielded significant
secondary structure changes in the mutants. Mutant M8
(K479R) showed a CD spectrum similar to M8(K479N)
whereas M8(K525R) showed a CD spectrum similar to
M8(K525Q), suggesting these mutants share similar struc-
tures (Figure 5C and D). However, neither M8(K479N)
Table 1 Cholix toxin catalytic fragment variants contain arginine (R) to lysine (K) replacement mutations
Rt oK
mutants






M1 R506K,R566K 170 150.7± 1
M2 R426K,R473K,R506K,R566K,R629K 205 173± 3.4
M4 R426K,R473K,R506K,R519K,R522K,R566K,R629K 250 197.8± 4.6
M4392 R426K,R473K,R506K,R519K,R522K,R540K,R566K,R629K 113 105.4± 1
M4421 R426K,R473K,R506K,R519K,R522K,R543K,R566K,R629K 100 79.4±5.9
M4781 R426K,R473K,R479K,R506K,R519K,R522K,R566K,R629K 130 126.6± 2
M5-2 R426K,R473K,R506K,R519K,R522K,R540K,R543K,R566K,R629K 100 7.8± 1.7
M5-4 R426K,R451K,R473K,R506K,R519K,R522K,R540K,R543K,R566K,R629K 155 8.2± 0.8
M6 R426K,R451K,R473K,R506K,R519K,R522K,R535K,R540K,R543K,R566K,R629K 90 9.6± 1.8
M6781 R426K,R451K,R473K,R479K,R506K,R519K,R522K,R535K,R540K,R543K,R566K,R629K 0 50±1.5
M7 R426K,R451K,R473K,R506K,R519K,R522K,R525K,R535K,R540K,R543K,R566K,R629K 70 1 ±3
M8 R426K,R451K,R473K,R479K,R506K,R519K,R522K,R525K,R535K,R540K,R543K,R566K,R629K 0 52.1±1.7
WT *- 215 206.3± 8.6
ǂ Data show the mean fluorescence of intensity of biotin signals on the auto-ADP-ribosylated enzyme band detected by IRDye800-SA.
¶Data show the specific activity of each enzyme as described in Methods.
*Wild type cholix toxin catalytic fragment (WT) contains R426, R451, R473, R479, R506, R519, R522, R525, R530, R535, R540, R543, R566, R629.
Sung and Tsai BMC Biochemistry 2014, 15:26 Page 9 of 22
http://www.biomedcentral.com/1471-2091/15/26nor M8(K525Q) showed higher biotin substitution than
M8(K479R) or M8(K525R) in the auto-ADP-ribosylation
(Figure 5E). These data are consistent with previous re-
ports that arginine is the preferred target residue for auto-
ADP-ribosylation [20-22,26,28,36,37].
Human ADPRH hydrolysis analysis
Human ADP-ribosylarginine hydrolase (hADPRH) has
been shown to preferentially hydrolyze the α-anomer of
ADP-ribosylarginine to release ADP-ribose from ADP-
ribosylated protein [38]. Pseudomonas aeruginosa exo-
toxin T (Exo T) is an ADP-ribosyltransferase which
specifically ADP-ribosylates arginine residues on target
proteins in the presence of a host co-factor, FAS [8]. A
Figure 5 Auto-ADP-ribosylation prefers arginines as target residues. Mutant M8 contains 13 arginines (R) to lysines (K) replacement
mutations except Arg530. (A) The same amount of M8 and its catalytically inactive form M8(YEDQ) were incubated with various concentrations of
biotinyl-NAD
+ in the auto-ADP-ribosylation reaction. The arrow indicates the biotinylated bands. (B) Mutant M8 was used as template for the K to
R reverse mutation to determine which arginine(s) could be auto-ADP-ribosylated. The arginines present in the M8 and M8 derived mutant enzymes
are indicated with their numerical positions in the full-length recombinant cholix toxin shown at the bottom of panel B. (C-E) Variation of acceptor
residues were carried out by replacing Lys479 or Lys525 on the mutant M8 with arginine (R), glutamine (Q), asparagine (N), or cysteine (C). The
circular dichroism of these M8 derived mutants were shown in (C) and (D). Auto-ADP-ribosylation was performed with wild type or mutant cholix
toxin catalytic fragments and detected by Western blotting shown in (E). Arrowheads indicate biotinyl-auto-ADP-ribosylation of the catalytic fragments.
Arrows indicate detection of the catalytic fragments by anti-CTc antibody for protein loading control.
Table 2 Kinetic analysis of auto-ADP-ribosylation of
various arginines on M8 derived mutants
Km, biotin-NAD (μM) Vmax (μM/min)
M8(K506R) 31.7±28.2 21767± 700.8





*n.d., cannot be determined. The values represent the mean ± standard error
from 11 different experiments with two to three repeats in each experiment
using GraphPad Prism 5.01.
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adaptor protein fused to the C-terminal domain of
Clostridium perfringens enterotoxin (CCPE), named
exoT substrate, was shown to be specifically ADP-
ribosylated by ExoT/FAS complex (Tsai, manuscript
in preparation). To understand the intermediate step
of the auto-ADP-ribosylation of cholix toxin, we com-
pared the activity of hADPRH on substrates formed by
cholix toxin auto-activity or ExoT action on its substrate.
Figure 6A and B show that hADPRH was able to effect-
ively hydrolyze the biotinylated ADP-ribosylarginine from
the ADP-ribosylated exoT substrate (> 80% reduction)
whereas only 20-40% reduction of the auto-ADP-
ribosylation of wild type CTc was observed after 30 mi-
nutes of hydrolysis reaction. Upon increasing hydroly-
sis incubation time, the biotin signals on the auto-
ADP-ribosylated wild type CTc increased whereas the
biotin-signals on the ADP-ribosylated exoTs u b s t r a t e
decreased, suggesting the removal of ADP-ribose from
t h ea u t o - A D P - r i b o s y l a t e dC T cm a yc a u s et h ee n z y m e
to become more active. Wild type CTc has multiple ar-
ginines to serve as ADP-ribose acceptors. We specu-
lated the increasing biotin substitution after hADPRH
treatment could be attributed to more arginines being
Figure 6 Auto-ADP-ribosylation results a mixture of α-a n dβ-anomeric ADP-ribosylargininyl adducts. (A) Auto-ADP-ribosylated wild
type CTc or M8 derived mutants or the ADP-ribosylated exoT substrate was incubated with purified hADPRH for various periods of time. The
biotinyl-ADP-ribosylation remaining was detected by blotting with IRDye800CW-SA and quantified by Odyssey Infrared imaging system. The
data shown in (A) are representative blots from multiple experiments. Five independent experiments were quantified and summarized in
(B). Data from 3 different experiments of hydrolysis of auto-ADP-ribosylated M8K525R, M8K543R and M8K566R were summarized in (C).T h e
error bar shows standard error of mean (SEM). Hydrolysis index is the ratio of normalized biotin signals remained on the hADPRH treated
versus untreated substrates. (D) Auto-ADP-ribosylation of catalytic fragments of exotoxin A (PEA) and cholix toxin (CTc) was carried out with
various concentrations of biotinyl-NAD
+ in the ADP-ribosylation buffer containing 3 μM of purified enzymes shown in top panel. The bottom
panel shows the Coomassie blue stained bands for protein loading control.
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therefore examined the hADPRH hydrolysis of the
auto-ADP-ribosylated M8(K525R), M8(K543R) and M8
(K566R), in which only two arginine residues are present
in each mutant enzyme. The biotin signal of each auto-
ADP-ribosylated M8 K to R mutant was reduced upon in-
cubation with hADPRH though these mutants displayed
different degrees of sensitivity to hADPRH hydrolysis
(Figure 6C; Additional file 3). M8(K540R) and M8(K566R)
exhibited a 10-20% of reduction in the auto-ADP-
ribosylation signals after 120 minutes of incubation
with hADPRH whereas M8(K525R) and M8(K543R)
showed 40-50% reductions, possibly indicating steric
factors may affect the accessibility of hADPRH to certain
ADP-ribosylarginine residues.
Free ADP-ribose, generated by hADPRH hydrolysis ac-
tivity, reacting with lysine to form Schiff-base adducts did
not attribute to the increased resistance of auto-ADP-
ribosylated CTc to hADPRH hydrolysis because no increases
of resistance was observed in M8(K543R), M8(K540R), M8
(K525R) nor in exoT substrate. ADP-ribosylation of exoT
substrate at 37°C resulted in a small proportion of ADP-
ribosylated exoT substrate (~20%) becoming more resistant
to hADPRH hydrolysis than the exoT substrate that was
ADP-ribosylated at 25°C. However, no difference was
observed in the rates of hydrolysis between ADP-ribosylated
exoTat 37°C and 25°C, suggesting no spontaneous anomeri-
zation occurred during the hADPRH hydrolysis reaction at
37°C. Thus, the possibility of spontaneous anomerization of
α-t oβ-ribosyl linkage in ADP-ribosylarginine at 37°C, ob-
served in choleragen [39], can not completely explain the
degree of resistance to hADPRH hydrolysis seen in the
auto-ADP-ribosylated CTc. Together, these data suggest that
ADP-ribosylation carried by ExoT/FAS complex is an SN2-
like reaction; whereas auto-ADP-ribosylation of CTc has
mixed stereochemistry consistent with an SN1-like reaction
mediated through diffusible intermediates.
Auto-ADP-ribosylation model
To understand what this diffusible intermediate was, we
first ruled out the possibility of the diffusible intermedi-
ate to be the ADP-ribose generated by the NAD
+ glyco-
hydrolase activity of the enzyme by free ADP-ribose
competition assays shown in Figure 1F and G. Moreover,
ADP-ribose has been shown to primarily interact with
lysine, not arginine, residues at neutral pH. Decreases of
biotin signals on a series of composed arginine to lysine
substitution mutants was observed whereas lysine to ar-
ginine reverse mutants restored the biotin signals on the
auto-ADP-ribosylated enzyme, indicating arginine is the
primary target residue for the auto-ADP-ribosylation of
CTc. However, we cannot exclude that lysine residue
may contribute to some level of biotin signals appeared
on the M8 mutant (Figure 5A).
The identification of the distal arginine residues, like
Arg540, Arg543 and Arg566, being auto-ADP-ribosylated,
suggests that this diffusible intermediate should be rela-
tively stable in aqueous solution. The estimated half life of
oxocarbenium ion, another well described intermediate, in
aqueous solution is about 10 to 100 ps [40,41], which is
too short to accommodate the time required for the inter-
mediate to diffuse out of NAD
+ binding pocket to react
with the arginine target residues located at the distal sites
before it reacts with water. Literature estimates for the




dict that on the order of 4 to 400 ns would be required for
the intact NAD
+ molecule to diffuse 1 to 10 nm. Because
rotational diffusion is typically orders of magnitude faster
than translational diffusion and the predicted rotational
relaxation time (rotational correlation time) of a protein
with the approximate dimensions of CTc is about 15 ns
[45], a combination of rotational and translational diffu-
sions of both NAD
+ and the enzyme would allow the dis-
tal sites on the opposite face of the enzyme to be reached
within tens of nanoseconds. We thus hypothesize that the
intermediate is a strained form of reactive NAD
+.I ti s
known that rate acceleration by enzymes could at least in
part be due to introduction of strain into the part of the
substrate which is undergoing reaction. The rate enhance-
ment which is found upon introduction of strain into the
substrate molecule by distortion can be very profound.
This type of rate acceleration is thought to increase the
energy of the ground state rather than to decrease the
peak of the activation energy curve [46].
One obvious question is how this strained NAD
+ inter-
mediate was formed. We previously observed Pseudomonas
exotoxin A has much lower auto-ADP-ribosylation ac-
tivity than cholix toxin when similar levels of NAD
+
substrate were used in the auto-ADP-ribosylation reac-
tions. Pseudomonas aeruginosa exotoxin A, another mem-
ber of the diphthamide-dependent ADP-ribosyltransferase
family, shares 30% identity to cholix toxin and has similar
numbers of arginines in the catalytic fragments (18 argi-
nines in exotoxin A; 14 arginines in cholix toxin). If
biotinyl-NAD
+ by itself is capable of reacting with argi-
nines, the same concentration of biotinyl-NAD
+ used
in the auto-reaction of exotoxin A and cholix toxin
should yield similar level of biotin signals on both enzymes.
Figure 6D shows that exotoxin A (Km,ε-NAD
+ =2 39 . 7±
89.79 μM) requires a much higher concentration of
biotinyl-NAD
+ to reach a similar level of auto-ADP-
ribosylation signal as cholix toxin (Km,ε-NAD
+ = 186.9 ±
87.79 μM). Km,ε-NAD
+ o ft h ee n z y m eb yd e f i n i t i o ni st h e
substrate concentration required to reach half of the
maximal velocity of its NAD
+ glycohydrolase activity.
Previously, Oppenheimer proposed a model for the in-
ductive stabilization of an oxocarbenium ion intermediate
via an interaction between the 2′-hydroxyl and an active
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such as diphtheria toxin and exotoxin A, in an enzyme-
mediated NAD
+ hydrolysis mechanism [16]. Cholix toxin,
like the other members of DT family, has glutamic acid
(E) as its catalytic residue. Glutamic acid has a pKa of 4.8.
At neutral pH, its carboxyl group is predominately nega-
tively charged. Here we hypothesize that a strained NAD
+
intermediate is pre-protonated at the catalytic site and re-
leased from the site before nicotinamide fully dissociated
from the ribose while the enzyme is actively processing
the substrate with its maximum speed (Figure 7A). The
strained NAD
+ intermediate then rotates to interact with
arginine residues in proximity. This would provide an ex-
planation for which exotoxin A required higher concen-
tration of NAD
+ substrate than cholix toxin did to reach
similar level of auto-ADP-ribosylation when similar num-
bers of arginine target residues were available on both en-
zymes. Following the release of this pre-protonated NAD
+
intermediate, the guanidinium group of arginine side
chain (pKa~12.43) approaching the partially negatively
charged 2′-hydroxyl of the strained NAD
+ intermediate
leads to the complete dissociation of nicotinamide to form
an oxocarbenium cation with an electrophilic C1 atom
which then immediately reacts with the partially nega-
tively charged nitrogen (nucleophilic atom) of the guanidi-
nium group of the target arginine (Figure 7B) to finish the
nucleophilic substitution reaction.
Figure 8 shows poly-L-arginines could enhance the
auto-ADP-ribosylation of CTc up to 7–fold at the con-
centration of 200 ng/mL. Poly arginines are commonly
found around the substrate binding domains of the
ADP-ribosyltransferases known as arginine fingers. These
arginines are located closely to the NAD
+ binding pocket.
The location of the poly arginines may alternatively
provide an environment to facilitate the auto-ADP-
ribosylation of the enzyme in the presence of NAD
+
and absence of the exogenous substrate, like eEF2 for
cholix toxin.
ADP-ribosylation of endogenous versus exogenous
substrates
Similar to several other ADP-ribosyltransferases [20,21,23],
if we pre-incubated CTc with NAD
+ to allow auto-
ADP-ribosylation to occur prior to analysis, auto-ADP-
ribosylation of the CTc suppressed its NAD
+ glycohydrolase
activity and ADP-ribosyltransferase activity to modify
eEF2 (Figure 9A and B). Cholix toxin and exotoxin A
are both characterized as diphthamide-dependent ADP-
ribosyltransferases which modify eEF2 in nature. We also
found that CTc could modify exogenous oligo-arginine
peptides (Figure 9C). To understand how the enzyme
ADP-ribosylates exogenous substrates in the presence of
endogenous substrate, we mixed various amounts of puri-
fied catalytic fragments of cholix toxin or exotoxin A with
Figure 7 Hypothetical model for auto-ADP-ribosylation.
(A) Formation of the diffusible strained NAD
+ intermediate. At
pH 7.5, the negatively charged carboxylate of the catalytic residue
interacting with the 2′ hydroxyl group induced partial negative
charges at the 2′hydroxyl position and formation of pseudo ribose
diol to cause pre-protonation at C1′. This pre-protonated form of
NAD
+ is usually stabilized by the solvent molecules in its surroundings.
We propose a mechanism in which this pre-protonated NAD
+
intermediate gets released from the catalytic site and diffuses out
of the NAD
+ binding pocket prior to dissociation of nicotinamide
when enzyme is busy in processing high concentration of NAD
+.
(B) Transfer of ADP-ribosyl moiety from strained NAD
+ to arginine
residue. This pre-protonated NAD
+ intermediate approaches arginine
residue through the positive charged side chain of arginine and
interacts with the partially negatively charged pseudo ribose diol
(step 1). Guanidinium group of arginine side chain contains three
nitrogens. When one nitrogen is positively charged to interact
with the ribose diol group, the induced partially negatively
charged nitrogen (nucleophilic atom) interacts with the electrophilic
C1 center of the N-ribose to cause dissociation of nicotinamide and
formation of oxocarbenium ion which then immediately reacts with
the partially negatively charged nitrogen on the guanidinium group of
arginine to facilitate the transfer of ADP-ribose to the target arginine
residue (step 2 and 3).
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or Re1.22c cell lysate, containing a mutated eEF2 without
diphthamide modification, in the ADP-ribosylation reac-
tions. The auto-ADP-ribosylation of the input enzyme was
only found in highest concentration (1.2 μM) of CTc,
whereas the ADP-ribosylation of wild type eEF2 has
reached saturated signals with much lower concentrations
of the enzymes. In this experimental setting, auto-ADP-
ribosylation of exotoxin A was not detected even with
1.2 μM of the enzyme (Figure 9D). We further incubated
purified flag-tagged eEF2(wt) or flag-tagged eEF2(H715R),
with excess concentration of CTc to observe the kinetics
of auto-ADP-ribosylation in the presence of exogenous
substrates. The kinetics of ADP-ribosylation of flag-tagged
eEF2 was much faster than that of auto-ADP-ribosylation
of the enzyme or ADP-ribosylation of the flag-tagged
eEF2(H715R) mutant, in which diphthamide was replaced
with an arginine residue (Figure 9E). Diphthamide, which
has imidazole-like structure on the modified histidine of
eEF2, was shown to directly contact NAD
+, and suggested
to be involved in triggering the cleavage of NAD
+ and
interacting with the oxocarbenium intermediate during
the nucleophilic substitution reaction [31]. We also ob-
served low concentration of imidazole could enhance
the biotinyl-ADP-ribosylation signals on the modified
substrates (Additional file 4). These findings suggest
that diphthamide can act as a catalyst to make ADP-
ribosylation of eEF2 much more efficient than the
auto-ADP-ribosylation reaction of cholix toxin. More-
over, at the presence of both endogenous and exogen-
ous substrates, the binding of the exogenous substrate
would segregate the arginine residues around the NAD
+
binding pocket of the enzyme from interacting with the
reactive strained NAD
+ intermediate. Several arginine res-
idues around the NAD
+ binding pocket involved in sub-
strate recognition and binding are also target residues of
auto-ADP-ribosylation. Therefore, if the ADP-ribosylation
of exogenous substrate results in lethal effect or triggers
downstream of signal transduction pathways of the modi-
fied substrate, the negatively regulatory effect of the auto-
ADP-ribosylation may be neglected and this is most likely
to be true for most of bacteria toxins.
Figure 8 Poly-L-arginines enhanced biotin signals on the auto-ADP-ribosylated wild type CTc. (A) Various concentrations of free
poly-L-arginines (Poly-L-Arg) or L-arginine (L-Arg) were added to the auto-ADP-ribosylation reaction of CTc and incubated at 37°C for 1 hr.
(B) The biotinyl-auto-ADP-ribosylation signals were detected by Western blotting and presented as fold of change compared to the no
amino acid added sample. The data shown is representative of three different experiments.
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http://www.biomedcentral.com/1471-2091/15/26Figure 9 ADP-ribosylation of endogenous versus exogenous substrates. (A-B) Cholix toxin catalytic fragments were pre-incubated with or
without 50 μM NAD
+ at 37°C for 1 hour. Free NAD
+ was removed by gel filtration chromatography. The recovered enzymes were quantified.
Equal concentrations of auto-ADP-ribosylated CTc (pre-incubated with NAD
+) or control (non-auto-ADP-ribosylated CTc, processed through
auto-ADP-ribosylation reaction without NAD
+)w e r eu s e di nt h eN A D
+ glycohydrolase activity assays and ADP-ribosylation of eEF2 in 293 lysate.
(C) His-tagged oligo-L-arginine or oligo-L-asparagine peptides were incubated with purified recombinant wild type CTc, catalytically defective
mutant (Y493A) or catalytically active mutant (E579Q). The samples were analyzed by a 96-well plate based ADP-ribosylation assay. Data shown are
composite from two experiments with triplicates within-plate replicates. (D)Various concentrations of catalytic fragments of cholix toxin or exotoxin A
(PEA) was incubated with CHO or Re1.22c cell lysate at 37°C for 1 hr. The biotin signals on the ADP-ribosylated eEF2 and auto-ADP-ribosylated enzymes
were detected by IRDye800CW-SA shown on the top panel. The same blot was stripped and re-probed with anti-CTc and anti-eEF2 antibodies shown
in the middle panel. The bottom panel shows the Coomassie Blue stained gel for protein loading control. (E) To detect auto-ADP-ribosylation at the
presence of exogenous substrates, excess amount of CTc (6 μM) was incubated with purified flag-tagged wild type eEF2 (0.2 μM) or flag-tagged eEF2
(H715R) mutant (0.2 μM) at the presence of 50 μM biotinyl-NAD
+ for various periods of time.
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Here we show that auto-ADP-ribosylation reaction of
cholix toxin primarily involves the intramolecular trans-
fer of ADP-ribosyl moiety to multiple arginine residues
located around the NAD
+ binding pocket as well as dis-
tal sites on the opposite face of the enzyme. This process
is mediated through diffusible intermediates generated
upon enzyme activation. Kinetic studies of M8 derived
variants show the auto-ADP-ribosylation rates of the ar-
ginines at the proximal sites of the NAD
+ binding pocket
is significantly faster than those of the arginines located at
the distal sites, supporting the diffusion mechanism.
Owing to the extremely short half life of free oxocarbe-
nium ion in aqueous solution, we hypothesize that the
diffusible intermediate is a form of strained NAD
+ which
is pre-protonated at the catalytic site and released prior to
the dissociation of nicotinamide to react with proximal
arginine residues. This study elucidates the existence
of a diffusible strained NAD
+ intermediate that is dif-
ferent from the strained NAD
+ alleviation model of the
ADP-ribosylarginine reaction in the Ita toxin previ-
ously described [47,48]. We propose this mechanism
can be applied to engineer artificial ADP-ribosyltransferases
with alternative substrates by bringing substrates with argin-
ine residues (or other nucleophilic target residues) close to
the NAD
+ binding pocket to react with diffusible intermedi-




+ (abbr. as biotinyl-NAD
+; Trevigen), 1,
N
6-ethenoadenosine5′-monophosphate disodium salt (abbr.
as ethenoAMP; Sigma), nicotinamide 1,N
6-ethenoadenine
dinucleotide (abbr. ethenoNAD
+;S i g m a ) ,β-nicotinamide
adenine dinucleotide (MP Biomedicals, LLC), Adeno-
sine 5′-diphosphoribose (abbr. ADP-ribose; Sigma), and
Phosphodiesterase I from Crotalus Adamanteus venom
(Sigma). Cholix toxin-specific antisera were raised by
immunizing rabbits (abbr. as anti-CTc antibody, Affin-
ity Bioreagent) with purified recombinant cholix toxin
prepared in this study. All other reagents were from
commercial sources unless specified.
Cloning, expression and purification of recombinant
proteins
(i) CTc: The 211-residue catalytic fragment of cholix
toxin (GenBank accession no. AY876053) was assembled
from chemically synthesized DNA oligonucleotides with
a C-terminal 6xHis-tag (Genscript) and fused with outer
membrane porin (ompF) leader sequences to target the
protein expression to the periplasmic space of E.coli.
The resulting fragment was inserted into a derivative of
the pACYC184 vector in which the transcription of the
inserted fragment was directed by the araBAD promoter
under the control of the araC activator. The resulting
prokaryotic expression plasmid was transformed into
E.coli stain LC1062, which is a recA
+,e n d o A
− version
of E.coli strain MC1061. To induce recombinant pro-
tein expression one mL of overnight culture was inocu-
lated into 100 mL of Terrific broth containing 12.5 μg/mL
of chloramphenicol. The culture was grown to an OD600
of 0.5 at 37°C with vigorous shaking and cooled to 22°C
prior to the addition of 0.5 mg/mL L-arabinose and fur-
ther incubation at 22°C for 16 hours. The culture was
harvested by centrifugation at 6000×g for 15 min and
bacterial pellets were immediately frozen at −80°C. Ni-NTA
spin columns were used to purify microgram amount of wild
type and mutant catalytic fragment according to the manu-
facturer’s recommendation with slight modification. Briefly,
spin columns were equilibrated with column buffer (50 mM
NaH2PO4; 300 mM NaCl; 10 mM imidazole, pH 8.0).
Bacterial pellets (1 g) were resuspended in one mL of
Ni-NTA column buffer containing 1 mg/mL lysozyme
and incubated on ice for 30 min. The lysate was ho-
mogenized and centrifuged at 14,000×g, 4°C for 30 min.
The cleared supernatant was then loaded to a pre-
equilibrated Ni-NTA spin column (Qiagen) and centri-
fuged at 700×g for 2~ 4 min at room temperature. The
spin column then was washed twice with 600 μLo f
column buffer containing 20 mM imidazole. Finally,
the protein was sequentially eluted with 200 μLo ft h e
column buffer containing 50 mM, 90 mM, and 250 mM
imidazole. Five μL of each fraction was analyzed by SDS-
PAGE followed by Coomassie Blue staining. The fractions
containing purified protein were pooled and concentrated
by Microcon YM-10 (Millipore) centrifugation. R530A,
R530Q, R540K, and M8 derived mutants were purified by
Ni-NTA spin column as described above, followed by
Superdex200 (GE Healthcare) gel filtration chromatog-
raphy purification in 10 mM HEPES buffer, pH 7.5 with a
molecular weight about 26 kDa. (ii) CXT and Ig-CTc:
CXT was codon optimized for E.coli expression and as-
sembled from chemically synthesized DNA oligonucleo-
tides with a C-terminal 6xHis-tag. The resulting DNA
fragment was inserted into pET22(b) vector between
Nco I and Not I sites. For the construction of Ig-CTc,
sequences encoding a fusion protein were prepared by
replacing the DNA sequence of domain I of cholix
toxin with a DNA sequence encoding an anti-CD19
ScFv (HD37, peptide accession numbers CAA67618
and CAA67620) and inserting the combined sequence
into pET22(b) vector between Nco I and Not I sites.
An 18 amino acid linker (GGGGSGGGGSGGGGSGSS)
joined the heavy chain and the light chain domains.
The expression of CXT or Ig-CTc fusion protein in
BL21(DE3) cells was induced with 0.2 mM isopropyl-
β-D-thiogalactoside (IPTG) at 17°C overnight. A peri-
plasmic fraction was prepared containing the fusion
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Purified protein was dialyzed against PBS and stored
at −80°C in small aliquots. (iii) hADPRH: The open
reading frame of hADPRH was amplified from a cDNA
clone of Open Biosystem collections by PCR with primers
(5′-GGGATTCATATGGAGAAGTATGTGGCTGC-3′ and
5′-GGCTCGAGTAAGGGAAATTACAGTGTCTTC-3′)
a n dc l o n e di n t ot h eNde I and Xho I sites of pET30a(+)
vector. The plasmid was transformed into BL21(DE3)
strain of E.coli and induced with 0.3 mM IPTG at 20°C
for 16 hours. One gram of bacterial pellet was suspended
in 4 mL lysis buffer (50 mM Tris, pH8.0; 150 mM NaCl;
3m Mβ-mercaptoethanol (β-ME); 10 mM MgCl2; 0.1%
(v/v) Triton X-100). After lysis by sonication, the cell deb-
ris was removed by centrifugation at 20,000×g at 4°C for
30 min. The clear supernatant was passed through Ni-
NTA column and washed with 10 column volume of
washing buffer (50 mM Tris, pH 8.0; 300 mM NaCl;
3m Mβ-ME; 5 mM MgCl2), the protein was eluted in a
buffer containing 50 mM Tris (pH8.0), 300 mM NaCl,
3m Mβ-ME, 5 mM MgCl2 and 500 μMi m i d a z o l e .T h e
eluate was concentrated to a volume of 0.5 mL and dir-
ectly applied onto a Superdex 200 size-exclusion column
(GE Healthcare). Human ADPRH eluted in a buffer con-
taining 50 mM Tris (pH 8.0), 150 mM NaCl and 2 mM
DTT with a molecule weight about 40 kDa and was fur-
ther dialyzed against 50% glycerol in 50 mM potassium
phosphate buffer (pH7.5) for storage at −20°C. (iv) Expres-
sion and purification of exoT substrate and ExoT/FAS
complex are to be described by Tsai (manuscript in prep-
aration). Briefly, a tandem repeat of a minimal four amino
acid peptide derived from Crk-I/II adaptor protein was
fused to the C-terminal domain of Clostridium perifrin-
gens enterotoxin (CCPE) and the resultant fusion protein,
named exoT substrate, was cloned into pET28 (a) vector
with a 6xHis tag on the N-terminus. His-tagged ExoT or
FAS was cloned into pET28 (a) and purified by Ni-NTA
chromatography. The ExoT/FAS complex was co-purified
by size-exclusion chromatography. (v) Flag-tagged eEF2
(wt) and eEF2(H715R) mutant. The flag-tagged wild type
eEF2 was PCR-amplified from a cDNA clone of Open




TGTCCAGGAAGTTGTC-3′.T h eP C Rp r o d u c tw a s
inserted into a mammalian expression vector, pEAK15,
on EcoR Ia n dNot I sites. Mutant eEF2(H715R) was
made by replacing diphthamide-modification target resi-
due, His715, with arginine using primers: 5′-CCGACGC
CATCCGGCGCGGAGGGGGC-3′ and 5′-GCCCCCTC
CGCGCCGGATGGCGTCGG-3′, in a site-directed muta-
genesis reaction. Ten μgo fp E A K 1 5 - f l a g - e E F 2 ( w t )o r
pEAK15-flag-eEF2(H715R) was transfected into a 10-cm
plate of 85% confluent CHO cells with 40 μL of transfectin
(Bio-rad). Forty-eight hours post-transfection, the cells
were lysed in cell lysis buffer (50 mM Tris–HCl, pH 7.4;
100 mM KCl; 12.5 mM MgCl2; 1 mM EDTA; 10% gly-
cerol; 1 mM DTT; 0.1% NP40) containing EDTA-free pro-
tease inhibitor cocktails (Roche), and incubated on ice for
30 min prior to centrifugation at 14,000×g for 10 min. The
supernatant was incubated with anti-flag M2 EZ-resin
(Sigma) at 4°C overnight. The flag-tagged proteins were
pulled down by centrifugation at 8,000×g for 30 sec and
followed by washing the resin three times with the cell
lysis buffer. The flag-tagged proteins were then eluted
by 150 ng/mL of FLAG peptides (Sigma) in 20 mM
Tris–HCl (pH 7.4).
Mammalian cell culture
CHO and Re1.22c cells were cultured in Alpha-MEM
(Invitrogen) containing 5% iron enriched calf serum
(Hyclone). 293 cells were cultured in DMEM (Invitro-
gen) containing 10% iron enriched calf serum. CHO and
Re1.22c cells were obtained from Dr. David Neville. All
cell lines were cultured at 37°C, 5% CO2 incubator.
Site-directed mutagenesis
All mutants used in this study were generated by using
QuikChange Site-directed mutagenesis or QuikChange
Multi site-directed mutagenesis kits (Agilent) according
to the manufacturer’s instructions.
Periplasmic fraction preparation
Fifty μL of overnight cultured E. coli transformants
were inoculated into 5 mL of Terrific broth containing
12.5 μg/mL chloramphenicol. The cultures were grown
to an OD600 of ~0.5 at 37°C and cooled to 22°C before
addition of 0.5 mg/mL of L-arabinose. The cultures
were then continuously cultured at 22°C for 16 hours
before periplasm isolation. A 1 mL aliquot of each culture
was pelleted by centrifugation at 14,000×g for 2 min. The
pellet was suspended in 50 μL of periplasmic preparation
buffer (200 mM HEPES-NaOH, pH7.5; 20% sucrose;
1 mM EDTA; 30,000 U/mL lysozyme) and incubated at
room temperature for 5 min. Fifty μL of ice-cold water
w e r ea d d e da n dm i x e db yg e n t l et a p p i n gf o l l o w e db y
incubation on ice for 5 min. The periplasmic fraction
was then separated from spheroplasts and bacterial
debris by centrifugation at 10,000×g for 2 min and col-
lection of the supernatant.
Detection of auto-ADP-ribosylation of cholix toxin
catalytic fragment
To detect the auto-ADP-ribosylated catalytic fragment
in periplasmic fractions, 30 μg of periplasmic lysate was
incubated with ADP-ribosylation buffer (1 mM EDTA;
1 mM DTT; 20 mM Tris–HCl, pH7.5) containing 50 μM
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+ at 37°C for 1 hour. For detection of the
ADP-ribosylation of purified protein, 2 μg of each purified
enzyme was used. The reaction was terminated by adding
SDS-PAGE sample buffer and boiled for 5 min. The sam-
ples were then resolved in 4-12% Criterion XT Bis-Tris
gel with NuPAGE MES running buffer (Invitrogen). The
gel contents were transferred to nitrocellulose and de-
tected by blotting with either horseradish peroxidase
(HRP)-conjugated SA (KPL) for chemiluminescence de-
tection (PerkinElmer) or IRDye-800CW SA (LI-CORE
Biosciences) for quantitation by Infrared imaging (Odyssey,
LI-COR Biosciences).
For the radioactive detection of auto-ADP-ribosylation,
6 μM of purified enzyme was incubated with 50 μM
32P-
NAD
+ mix, which was prepared by dilution of [adenyl-
ate-
32P]-NAD
+ (800 Ci/mmol, PerkinElmer NEN) to a
final specific activity of 3 Ci/mmol with unlabelled β-NAD
+
(Sigma) to a final concentration of 100 μMN A D
+ mix, at
37°C for 1 hour. The reaction was terminated by addition
of 10 μg bovine serum albumin (BSA) and 10 μLo f1 0 0 %
tricholoroacetic acid (TCA) and incubated on ice for an
hour, followed by centrifugation at 13,000×g for 10 min,
washing the pellet once with 200 μLo fi c e - c o l da c e t o n e
and once with 200 μL of 95% ethanol, air-dry for 3 min
prior to addition of protein sample buffer and boiled for
5 min. The samples were resolved by 10% Criterion XT
Bis-Tris gel and the gel was heat-vacuum dried for 2 hours
before exposure to Kodak storage phosphor screen. The
image was scanned by Typhoon 9410 Variable Mode
Imager and analyzed by ImageQuant software.
The auto-ADP-ribosylation reaction was also performed
with various concentrations of [carobnyl-
14C]-NAD
+ in
the ADP-ribosylation buffer with 6 μMo fp u r i f i e dC T co r
CTc(YEDQ) mutant. The reaction was terminated by
addition of 10 μgB S Aa n d1 0μL of 100% TCA and incu-
bated on ice for an hour. Aliquots of 10 μL were spotted
to Whatman 3 MM filter paper (0.75-inch square), washed
twice with ice-cold 10% TCA and once in methanol
(10 mL for each wash of a square filter paper; 2.5 min per
wash). The level of radioactivity was counted in Beckman
LS1801 multipurpose scintillation counter or PerkinElmer
2900TR Tri-Carb Liquid scintillation analyzer.
Free ADP-ribose competition assays
(i) Radioactive detection: Various concentrations of free
ADP-ribose were added in duplicates of 30 μL of auto-
ADP-ribosylation reaction containing 7.6 μM purified
CTc, 20 mM Tris–HCl (pH 7.5), 1 mM EDTA, 2 mM DTT,
and 50 μM
32P-NAD
+ mix. The auto-ADP-ribosylation
reaction was carried out at 37°C for 90 min and the re-
action was stopped by addition of 1 μLo f1 0m g / m L
BSA and 10 μL of 100% TCA, followed by incubation on
ice for one hour. For the control experiment, the
32P-auto-
ADP-ribosylated CTc was treated with 0.067 U/mL
phosphodiesterase I at 37°C for up to 30 min, followed by
addition of BSA and TCA on ice for 1 hour. Aliquots of
10 μL were spotted to Whatman 3MM filter paper,
washed twice with ice-cold 10% TCA and once in
methanol. The level of radioactivity was counted with
3 mL scintillation cocktail in Beckman LS1801 multi-
purpose scintillation counter. (ii) Western blotting detec-
tion: Various concentrations (4.5 μM to 2.86 mM) of free
ADP-ribose were added to the auto-ADP-ribosylation re-
action with 3 μMp u r i f i e dC T c ,5 0μM biotinyl-NAD
+.
The biotinyl-auto-ADP-ribosylation signal was detected
by Western blotting as described above.
Immunoblot analysis
Wild type and mutant CTc or eEF2 in each transferred
membrane were exposed to rabbit polyclonal anti-CTc
antibody, rabbit polyclonal anti-eEF2 antibody (Abcam),
or mouse anti-flag (M2) monoclonal antibody (Sigma)
followed by different secondary antibodies. For hADPRH
detection, rabbit polyclonal anti-hADPRH antibody (Ab-
sent) was used. For the detection of exoT substrate,
rabbit polyclonal anti-his tag antibody (Santa Cruz) was
used. Strong Re-blot buffer (Millipore) was used to stripe
the membrane for re-blotting with different antibodies.
For the chemiluminescence detection, HRP-conjugated
goat anti-rabbit IgG (Promega) was used as secondary
antibody; for the infrared imaging detection, IRDye680
conjugated goat anti-rabbit or IRDye680 conjugated anti-
mouse antibody (LI-COR Biosciences) was used.
Hydroxylamine sensitivity assay
To characterize ADP-ribosylated residues the auto-ADP-
ribosylation reaction of wild type and mutant cholix toxin
catalytic fragments were conducted at 37°C for 1 hour as
described above. The reaction products were adjusted to
0.5 M NH2OH (pH7.5) or 0.5 M NaCl and incubated at
37°C for various periods of time. The reactions were ter-
minated by addition of 4x sample buffer, boiled for 5 min
and fractionated and blotted as described above.
Plate-based auto-ADP-ribosylation assay
Wild type or mutant catalytic fragment (1.5 μg) was in-
cubated with 50 μM biotinyl-NAD
+, 10 mM HEPES-
NaOH (pH7.5) and 2 mM MgCl2 at 37°C for 1 hour.
The mixture was then added to a 96-well Ni-NTA plate
and incubated for 2 hours on ice. The plate was washed
with 1 M (NH4)2SO4 in PBS for 4 times, followed by
washing with PBST (1% Tween 20 in PBS) twice. HRP-
conjugated SA was then added to the plate and incu-
bated for 30 min at room temperature. The plate was
washed 8 times with PBST and developed by addition of
50 μL 1.25 mM tetramethylbenzidine (TMB) solution.
The reaction was stopped by addition of 50 μLo f
250 mM HCl and the absorbance measured at 450 nm.
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(i) ADP-ribosylation of artificial peptide substrates: The
peptides R10H6 and N10H6 were chemically synthesized
(Invitrogen). Purified enzyme (1.5 μg) was incubated
with 1 mg/mL of R10H6 or N10H6 in a buffer contain-
ing 50 μM biotinyl-NAD
+, 10 mM HEPES-NaOH (pH7.5)
and 2 mM MgCl2 at 30°C for 30 min. The mixture was
then added to a 96-well Ni-NTA HisPrime plate (5 PRIME
Inc.) and incubated for two hours on ice. The plate was
washed with 200 μLo f1M( N H 4)2SO4 in PBS for 4 times
and 200 μLP B S Tt w i c e .F i f t yμLo f0 . 5μg/mL HRP-
conjugated SA was then added to the plate and incubated
for 30 min at room temperature. The plate then was
washed 8 times with 200 μL of PBST and developed by
addition of 50 μL of TMB solution. The reaction was
stopped by addition of 50 μL of 250 mM HCl and the ab-
sorbance measured at 450 nm. (ii) ADP-ribosylation of
eEF2: CHO or Re1.22c cells were lysed in cell lysis buffer
(50 mM Tris, (pH7.9); 100 mM KCl; 12.5 mM MgCl2;
1 mM EDTA; 10% glycerol; 1 mM DTT; 0.1% NP40) with
protease inhibitors. For the ADP-ribosylation of endogen-
ous eEF2 in cell lysate by the catalytic fragments of cholix
toxin or exotoxin A, five μg of total cell lysate was added
in a 25 μL ADP-ribosylation reaction with various concen-
trations of purified enzyme and the ADP-ribosylation
assay buffer containing 50 μM biotinyl-NAD
+. For the
ADP-ribosylation of flag-tagged wild type or mutant eEF2,
0.5 μg of purified flag-tagged protein was incubated with
4 μgo fp u r i f i e dC T ci na2 5μL ADP-ribosylation reaction
containing 50 μMb i o t i n y l - N A D
+. The reaction was car-
ried out at 37°C for various durations, and analyzed by
Western blotting.
Circular Dichroism (CD) spectrum analysis
CD spectra were recorded on a Circular Dichroism
Spectrometer Model 202 (AVIV Instruments, Inc.,
Lakewood, NJ) in a quartz cell with an optical path of
1 mm at 25°C. Purified proteins were dialyzed against
de-gassed 10 mM HEPES buffer (pH 7.5) and 5 μMo f
purified wild type and mutant CTc was used in the
analysis. The samples were scanned from 185 or 200 nm
to 300 nm with 1 nm increment. The signal was recorded
from the average of 4 measurements for each wavelength
with an averaging time of 5 seconds. Buffer control was
scanned between each cell wash. The CD data of each
sample scan was subtracted from the buffer only data col-
lected before measurement of each protein sample.
NAD
+ glycohydrolase activity assays
A fluorometric assay based on ethenoNAD
+ was used to
quantify the NAD
+ glycohydrolase activity of the wild
type and mutant catalytic fragments [49]. In brief, in a
25 μL reaction, 6 μg of purified catalytic fragment
was incubated with 0.4 mM ethenoNAD
+ in a buffer
containing 10 mM HEPES-NaOH (pH 7.5) and 2 mM
MgCl2 at 37°C for 90 min. The reaction was stopped
by addition of 100 μLo f1 2 . 2m ME D T Ai n1 0m M
HEPES-NaOH, pH7.5. The fluorescence was measured
in a plate reader (Gemini EM, Molecular Devices) with ex-
citation at 305 nm and emission at 410 nm and results
were corrected for background fluorescence formed in the
absence of enzyme to obtain the relative fluorescence
units (RFU). EthenoAMP, used to generate the standard
curve, was taken to have the same molar extinction and
emission coefficients as ethenoADP-ribose. The specific
activity was calculated in units/mg purified protein. One
unit is defined as one nmol ADP-ribose formed in 90 min
at 37°C.
Kinetic experiments
Initial rate data for the auto-ADP-ribosylating specific
arginines in M8 derived mutants were determined by in-
cubation of 5 μM of purified enzymes with various con-
centrations of biotinyl-NAD
+ from 5 to 100 μM in the
ADP-ribosylation buffer at 37°C for 15 min. The reac-
tions were immediately stopped and analyzed by Western
blotting described above. The initial velocity (Vi,15min)o f
the auto-reaction in M8 or M8 derived mutants was
calculated by the following equation: Vi,15min =(F I, 15min-
FI,0min)/15 min. FI,15min or FI,0min is the fluorescence
intensity of the auto-ADP-ribosylation signals semi-
quantified by Odyssey Infrared Imaging system after
15 min incubation at 37°C, or at time 0, when various
enzymes were boiled with protein sample buffer imme-
diately after addition of ADP-ribosylation buffer con-
taining various concentrations of biotinyl-NAD
+.T h e
rate of auto-ADP-ribosylation of Arg506, Arg519, Arg525,
Arg540, Arg543 or Arg566 was determined by GraphPad
Prism 5.01 using non-linear regression fitting of RVi,15min
in the Michaelis-Menten Model. RVi,15min=(Vi,15min of
M8K506R, M8K519R, M8K525R, M8K540R, M8K543R
or M8K566R mutant)- (Vi,15min of M8 mutant).
2-D gel analysis of auto-ADP-ribosylated proteins or
peptides
Eight μg of purified CTc was incubated at 37°C in a buffer
consisting of 20 mM Tris, pH 7.5 and 250 μMN A D
+.
After 90 min, the reaction was stopped by removal of free
unincorporated NAD
+ using Illustra MicroSpin G-25 Col-
umns (GE Healthcare). The sample was diluted in a rehy-
dration/sample buffer (6 M urea, 1.5% CHAP, 37.75 mM
DTT, 0.15% w/v Bio-Lyte 3/10 ampholytes, 5 mM Tris–
HCl, pH 7.5 and trace amount of bromophenol blue) with
1:10 ratio. The diluted sample was evenly distributed to
the IPG strip (pH 3–10 or pH 5–8) and overlaid with min-
eral oil to avoid evaporation. The rehydration of IPG strip
was carried out in the PROTEIN IEF Focusing Tray in the
PROTEIN IEF Cell under passive condition for 20 hrs
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cusing method was used to program PROTEIN IEF Cell
(step 1: voltage from 0 to 250 V, in 15 min with rapid
ramp mode; step 2: voltage starts from 250 to 8000 V, in
2 hrs and 30 min with slow ramp mode; step 3: voltage is
kept at 8000 V for 25,000 volt-hours with rapid mode)
with the temperature set at 20°C and the current limit set
at 50 μA/IPG strip. After the first dimensional isoelectric-
focusing (IEF), the IPG strips (pH 3–10 or pH 5–8) were
equilibrated in reducing buffer containing 6 M urea, 2%
SDS, 0.375 M Tris–HCl (pH8.8), 20% glycerol and 2%
DTT at room temperature for 15 min and followed by al-
kylation with 2.5% w/v iodoacetamide in 6 M urea, 2%
SDS, 0.375 M Tris–HCl (pH8.8) and 20% glycerol at room
temperature for an additional 15 min. The equilibrated
IPG strip was placed horizontally on the Criterion XT
4-12% Bis-Tris (prep+1 well Comb) gel and the pro-
teins on the IPG strip were electrophoresed at 200 V
for 45 min. For the peptide 2-D analysis, ten μgo f
auto-ADP-ribosylated CTc was incubated with 0.8 μg
of LysC (Thermo Inc.) in 100 mM ammonium biocar-
bonate, pH 8.0 at 37°C for 6 hrs. The proteolytic prod-
ucts were separated by first-dimensional IEF using pH 3–10
IPG strips, followed by 16.5% Tris-Tricine peptide (prep+2
well Comb) gel electrophoresis for second dimensional sep-
aration. The gels then were stained with Coomassie Brilliant
Blue R-250.
MS/MS analysis
Peptide from 2-D gel spots were analyzed by MS/MS
analysis (Osago et al. manuscript in preparation). Briefly,
each individual spot was destained, dried, and digested
with V8 protease in 50 mM ammonium bicarbonate
(pH 8.3) at 37°C overnight. Mass spectra of the digested
peptides were acquired on a nanoLC-MALDI-TOF/TOF
system (KYA Technologies DiNa nana-HPLC system-AB
SCIEX TOF/TOF 5800) using 4000 Series Explorer
(version 3.6). The data were analyzed with version 3.0
ProteinPilot
TM software.
Human ADPRH hydrolysis assay
(i) Substrate preparation: Auto-ADP-ribosylation of CTc
and M8 derived mutants were performed as the reaction
described above at 37°C for an hour unless otherwise
noted, followed by removal of free unincorporated biotinyl-
NAD
+ with NAP-5 columns (GE HealthCare). ADP-
ribosylation of exoT substrate was performed by incu-
bation of purified 2 μM exoT substrate with 50 nM
ExoT, 200 nM FAS in PBS with 5 μMb i o t i n y l - N A D
+
at 25°C or 37°C for 1 hr. The reaction was terminated by
removal of free unincorporated biotinyl-NAD
+ with NAP-5
columns. (ii) Hydrolysis assay: The ADP-ribosylated sub-
strates were incubated with 2.5 U of purified hADPRH in
PBS buffer containing 10 mM MgCl2,a n d5m MD T Ti na
total volume of 25 μL for various time points at 37°C. Reac-
tions were stopped by addition of protein sample buffer and
boiling for 5 min. The sample was then subjected to SDS-
PAGE and blot analysis as described above. One unit (U) of
hADPRH defines the amount of purified hADPRH removal
of greater than 70% of biotinyl-ADP-ribosylarginines from
0.5 μg of ADP-riobsylated exoTsubstrateina25μL reaction
at 37°C for an hour. (iii) Hydrolysis index: The spontaneous
hydrolysis of ADP-ribosylarginines without hADPRH is ob-
served in many in vitro ADP-ribosylation reactions. Con-
tinuous ongoing auto-ADP-ribosylation activity is also in
some cases even after the removal of free biotinyl-NAD
+ by
gel filtration chromatography. Therefore, we define the hy-
drolysis index as the ratio of normalized fluorescent inten-
sity (FI) of the hADPRH treated sample to the normalized
FI of untreated sample. Normalized FI of each sample
is the raw fluorescence intensity of IRDye800CW-SA
divided by the raw fluorescence intensity of IRDye680.
The hydrolysis index was then used to calculate the
percentage of reduction of biotinyl-ADP-ribosylarginine
signals after various periods of incubation time. The per-
centage of reduction then can be translated into the sus-
ceptibility of the ADP-ribosylargininyl adduct on each
modified protein to hADPRH hydrolysis.
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